EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieValidierungsstudieOpen Access · CC BY-NC 4.0

Prediction of new‐onset heart failure in patients with type 2 diabetes derived from ALTITUDE and CANVAS

Fatema Said iD, Clare Arnott, Adriaan A Voors, Hiddo J L Heerspink iD, Jozine M Ter Maaten

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15592 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Fatema Said und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Heart Failure, Peptide Fragments, Natriuretic Peptide, Brain. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To create and validate a prediction model to identify patients with type 2 diabetes (T2D) at high risk of new‐onset heart failure (HF), including those treated with a sodium‐glucose cotransporter‐2 (SGLT2) inhibitor.

Methods

A prediction model was developed from the Aliskiren Trial in Type 2 Diabetes Using Cardiorenal Endpoints (ALTITUDE), a trial in T2D patients with albuminuria or cardiovascular disease. We included 5081 patients with baseline N‐terminal pro B‐type natriuretic peptide (NT‐proBNP) measurement and no history of HF. The model was developed using Cox regression and validated externally in the placebo arm of the Canagliflozin Cardiovascular Assessment Study (CANVAS), which included 996 participants with T2D and established cardiovascular disease or high cardiovascular risk, and in patients treated with canagliflozin.

Results

ALTITUDE participants (mean age 64 ± 9.8 years) had a median serum NT‐proBNP level of 157 (25th–75th percentile 70–359) pg/mL. Higher NT‐proBNP level, troponin T (TnT) level and body mass index (BMI) emerged as significant and independent predictors of new‐onset HF in both cohorts. The model further contained urinary albumin‐to‐creatinine ratio, glycated haemoglobin, age, haematocrit, and use of calcium channel blockers. A prediction model including these variables had a C‐statistic of 0.828 (95% confidence interval [CI] 0.801–0.855) in ALTITUDE and 0.800 (95% CI 0.720–0.880) in CANVAS. The C‐statistic of this model increased to 0.847 (95% CI 0.792–0.902) in patients after 1 year of canagliflozin treatment.

Conclusion

In patients with T2D, higher NT‐proBNP level, TnT level and BMI are independent and externally validated predictors of new‐onset HF, including patients using an SGLT2 inhibitor. This newly developed model may identify patients at high risk of new‐onset HF, contributing to early recognition and possibly prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Heart FailurePeptide FragmentsNatriuretic Peptide, BrainSodium-Glucose Transporter 2 InhibitorsHumansFemaleMiddle AgedMaleAgedCanagliflozinAmidesTroponin TAlbuminuriaBody Mass IndexBiomarkersRisk FactorsRisk AssessmentFumarates

Stichwörter der Autor:innen

NT‐proBNPSGLT2 inhibitornew‐onset heart failureprediction modeltype 2 diabetes mellitus

Substanzen

Peptide Fragmentspro-brain natriuretic peptide (1-76)Natriuretic Peptide, BrainSodium-Glucose Transporter 2 InhibitorsCanagliflozinAmidesTroponin TaliskirenBiomarkersFumarates

Autor:innen und Institutionen

  • Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • The George Institute for Global Health, Sydney, Australia.
  • Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

ORCID-Profile: Fatema Said, Hiddo J L Heerspink

Zitieren

APA

Said, F., Arnott, C., Voors, A. A., Heerspink, H. J. L., & Ter Maaten, J. M. (2024). Prediction of new‐onset heart failure in patients with type 2 diabetes derived from ALTITUDE and CANVAS. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15592

Vancouver

Said F, Arnott C, Voors AA, Heerspink HJL, Ter Maaten JM. Prediction of new‐onset heart failure in patients with type 2 diabetes derived from ALTITUDE and CANVAS. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15592

BibTeX
@article{Said2024,
  author = {Said, Fatema and Arnott, Clare and Voors, Adriaan A and Heerspink, Hiddo J L and Ter Maaten, Jozine M},
  title = {Prediction of new‐onset heart failure in patients with type 2 diabetes derived from ALTITUDE and CANVAS},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15592}
}
Kostenlos starten →